Mads Hald Andersen
Clinical Professor
Immunology
Blegdamsvej 3B, 2200 København N
Member of:
ORCID: 0000-0002-2914-9605
11 - 12 out of 12Page size: 10
- 2018
- Published
Immunoregulatory antigens-novel targets for cancer immunotherapy
Pedersen, A. W., Kopp, K. L., Andersen, Mads Hald & Zocca, M., Apr 2018, In: Chinese Clinical Oncology. 7, 2, p. 1-8 19.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin
Woetmann, Anders , Alhede, M., Dabelsteen, Sally, Bjarnsholt, Thomas, Rybtke, Morten Levin, Nastasi, C., Krejsgaard, T., Andersen, Mads Hald, Bonefeld, Charlotte Menne, Geisler, Carsten, Givskov, Michael & Ødum, Niels, 2018, In: OncoTarget. 9, 28, p. 19481-19489 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 13571778
Most downloads
-
216
downloads
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
170
downloads
Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
168
downloads
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin
Research output: Contribution to journal › Journal article › Research › peer-review
Published